AAM's letter requests that the FTC issue a section 6(b) Order to investigate the contracting practices of buying groups that contribute to the root causes of drug shortages.
The Association for Accessible Medicines submitted a formal statement for the record for the Senate Committee on the Judiciary hearing on drug pricing.